For all inquiries regarding Tissue Microarrays with survival data, please contact us at support@taibsbio.cn
首页 > 组织芯片 > 前列腺 > MPR1005
tissue microarray-MPR1005
  • 点数:
    100
    例数:
    100
    点样直径(mm):
    1
    厚度(µm):
    5
    行数:
    9
    列数:
    11
    组织阵列类型:
    种属:
MPR1005
加入收藏

描述: Prostate cancer tissue array, including TNM, clinical stage and Gleason scores, 100 cases/100 cores

详情: Prostate carcinoma tissue microarray, containing 100 cases of adenocarcinoma, single cores per case

应用程序: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Prostate
  • Malignant(*)
  • Malignant(II)
  • Malignant(III)
  • Malignant(IV)
组织芯片
MPR1005
1
2
3
4
5
6
7
8
9
10
11
A
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
B
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
C
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
D
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
E
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
F
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
G
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
H
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
I
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
MPR1005
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
位置 No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Gleason Score P504S
A1
1 / M Prostate Adenocarcinoma * * * Malignant 3+4 +
A2
2 / M Prostate Adenocarcinoma * * * Malignant 3+4 +
A3
3 / M Prostate Adenocarcinoma * * * Malignant 3+4 ++
A4
4 / M Prostate Adenocarcinoma (sparse) * * * Malignant 3+4 +++
A5
5 / M Prostate Adenocarcinoma * * * Malignant 3+4 +
A6
6 / M Prostate Adenocarcinoma * * * Malignant 3+4 ++
A7
7 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 ++
A8
8 58 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 3+4 ++
A9
9 59 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 +++
A10
10 57 M Prostate Adenocarcinoma * T2bN0M0 II Malignant 3+4 ++
A11
11 60 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 3+4 +
B1
12 72 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 ++
B2
13 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 3+4 +
B3
14 68 M Prostate Adenocarcinoma * T2cN0M0 II Malignant 3+4 +
B4
15 63 M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 3+4 +++
B5
16 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 +++
B6
17 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 +++
B7
18 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 3+4 ++
B8
19 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 3+4 ++
B9
20 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 +
B10
21 73 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 3+4 ++
B11
22 / M Prostate Adenocarcinoma * T3aN0M0 III Malignant 3+4 +
C1
23 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 3+4 ++
C2
24 69 M Prostate Adenocarcinoma * * * Malignant 4+3 ++
C3
25 / M Prostate Adenocarcinoma * * * Malignant 4+3 ++
C4
26 56 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+3 +
C5
27 73 M Prostate Adenocarcinoma * T2bN0M0 II Malignant 4+3 ++
C6
28 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+3 ++
C7
29 74 M Prostate Adenocarcinoma * T2cN0M0 II Malignant 4+3 ++
C8
30 81 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+3 +
C9
31 68 M Prostate Adenocarcinoma * T2bN0M0 II Malignant 4+3 +
C10
32 / M Prostate Adenocarcinoma * * * Malignant 4+3 ++
C11
33 / M Prostate Adenocarcinoma * * * Malignant 4+3 ++
D1
34 / M Prostate Adenocarcinoma * * * Malignant 4+3 +++
D2
35 / M Prostate Adenocarcinoma * * * Malignant 4+3 ++
D3
36 / M Prostate Adenocarcinoma * * * Malignant 4+3 ++
D4
37 / M Prostate Adenocarcinoma * * * Malignant 4+3 +
D5
38 / M Prostate Adenocarcinoma * * * Malignant 4+3 +
D6
39 / M Prostate Adenocarcinoma * * * Malignant 4+3 ++
D7
40 / M Prostate Adenocarcinoma * * * Malignant 4+3 +
D8
41 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+3 +++
D9
42 79 M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+3 ++
D10
43 / M Prostate Adenocarcinoma * T3aN1M0 IV Malignant 4+3 ++
D11
44 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 4+3 ++
E1
45 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+3 ++
E2
46 78 M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+3 +++
E3
47 61 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 4+3 ++
E4
48 70 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+3 ++
E5
49 70 M Prostate Adenocarcinoma * T2cN0M0 II Malignant 4+3 ++
E6
50 68 M Prostate Adenocarcinoma * T2cN0M0 II Malignant 4+3 +
E7
51 69 M Prostate Adenocarcinoma * T2cN0M0 II Malignant 4+3 ++
E8
52 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+3 ++
E9
53 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+3 ++
E10
54 79 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 4+4 ++
E11
55 / M Prostate Adenocarcinoma * * * Malignant 4+4 ++
F1
56 57 M Prostate Adenocarcinoma * * * Malignant 4+4 +++
F2
57 / M Prostate Adenocarcinoma * * * Malignant 4+4 ++
F3
58 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+4 ++
F4
59 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 4+4 ++
F5
60 / M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+4 +
F6
61 / M Prostate Adenocarcinoma * T3aN0M0 III Malignant 4+4 ++
F7
62 75 M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+4 ++
F8
63 70 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+4 +
F9
64 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+4 +/-
F10
65 47 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 4+4 +
F11
66 78 M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+4 ++
G1
67 / M Prostate Adenocarcinoma * T3aN1M0 IV Malignant 3+5 ++
G2
68 / M Prostate Adenocarcinoma * T2cN0M0 II Malignant 3+5 ++
G3
69 60 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 3+5 +
G4
70 68 M Prostate Adenocarcinoma * T2bN0M0 II Malignant 5+3 ++
G5
71 66 M Prostate Adenocarcinoma * T3aN0M0 III Malignant 5+3 ++
G6
72 65 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 4+5 ++
G7
73 74 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+5 +
G8
74 61 M Prostate Adenocarcinoma * * * Malignant 4+5 +
G9
75 / M Prostate Adenocarcinoma * * * Malignant 4+5 ++
G10
76 / M Prostate Adenocarcinoma * * * Malignant 4+5 ++
G11
77 / M Prostate Adenocarcinoma * * * Malignant 4+5 +
H1
78 / M Prostate Adenocarcinoma * * * Malignant 4+5 ++
H2
79 / M Prostate Adenocarcinoma * * * Malignant 4+5 +
H3
80 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+5 ++
H4
81 68 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+5 ++
H5
82 / M Prostate Adenocarcinoma * T4N1M0 IV Malignant 4+5 ++
H6
83 73 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 4+5 ++
H7
84 / M Prostate Adenocarcinoma * T4N0M0 III Malignant 4+5 +
H8
85 / M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 4+5 +
H9
86 / M Prostate Adenocarcinoma * * * Malignant 5+4 +
H10
87 / M Prostate Adenocarcinoma * * * Malignant 5+4 ++
H11
88 / M Prostate Adenocarcinoma * * * Malignant 5+4 +
I1
89 57 M Prostate Adenocarcinoma * * * Malignant 5+4 +
I2
90 / M Prostate Adenocarcinoma * * * Malignant 5+4 +
I3
91 / M Prostate Adenocarcinoma * * * Malignant 5+4 +++
I4
92 / M Prostate Adenocarcinoma * T4N0M0 III Malignant 5+4 +++
I5
93 74 M Prostate Adenocarcinoma * T2cN1M0 IV Malignant 5+4 ++
I6
94 78 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 5+4 ++
I7
95 77 M Prostate Adenocarcinoma * T2cN0M0 II Malignant 5+4 ++
I8
96 72 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 5+4 +++
I9
97 71 M Prostate Adenocarcinoma * T3bN0M0 III Malignant 5+4 +++
I10
98 79 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 5+4 +
I11
99 56 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 5+4 +
J1
100 57 M Prostate Adenocarcinoma * T3bN1M0 IV Malignant 5+4 +
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们:support@arraysbank.com
0.084255s